lipopolysaccharide
Term · Oncology and biomedicine · MLC-T-ONC-014810
An endotoxin and biologically active component of the Gram-negative bacterial cell wall that is a Toll-like receptor 4 (TLR4) agonist with potential immunostimulatory activity. Upon internalization, lipopolysaccharide (LPS) activates TLR4 which in turn activates the NFkappaB pathway, in addition to mitogen-activated protein kinases signaling pathways. This leads to the release of proinflammatory cytokines and stimulates an innate immune response against vaccine antigens.
| Identifier | MLC-T-ONC-014810 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | LPS |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014810",
"term": "lipopolysaccharide",
"field": "Oncology and biomedicine",
"definition": "An endotoxin and biologically active component of the Gram-negative bacterial cell wall that is a Toll-like receptor 4 (TLR4) agonist with potential immunostimulatory activity. Upon internalization, lipopolysaccharide (LPS) activates TLR4 which in turn activates the NFkappaB pathway, in addition to mitogen-activated protein kinases signaling pathways. This leads to the release of proinflammatory cytokines and stimulates an innate immune response against vaccine antigens.",
"abbreviation": "LPS",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/lipopolysaccharide/"
}
Record 10,160 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.